Letter to the Editor Open Access
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 16, 2025; 13(17): 100439
Published online Jun 16, 2025. doi: 10.12998/wjcc.v13.i17.100439
Recurrent acute pancreatitis as an initial presentation of primary hyperparathyroidism in juvenile patient
Milena M Lackovic, Bojan D Joksimovic, Zoran M Gluvic, Department of Endocrinology, University Clinical-Hospital Centre Zemun-Belgrade, Faculty of Medicine, University of Belgrade, Belgrade 11080, Serbia
Jelena C Babovic, Department of Geriatrics, University Clinical-Hospital Centre Zemun-Belgrade, Faculty of Medicine, University of Belgrade, Belgrade 11080, Serbia
Esma R Isenovic, Department of Radiobiology and Molecular Genetics, Vinča Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade, Belgrade 11000, Serbia
ORCID number: Milena M Lackovic (0000-0001-8941-7723); Bojan D Joksimovic (0000-0001-9785-7665); Jelena C Babovic (0009-0002-7427-2538); Esma R Isenovic (0000-0002-0012-2636); Zoran M Gluvic (0000-0001-6371-6610).
Co-first authors: Milena M Lackovic and Bojan D Joksimovic.
Co-corresponding authors: Esma R Isenovic and Zoran M Gluvic.
Author contributions: Lackovic MM, Joksimovic BD, and Babovic JC analysed the data and wrote the manuscript; Lackovic MM and Joksimovic BD contributed equally to this article, they are the co-first authors of this manuscript; Isenovic ER and Gluvic ZM designed and edited the manuscript, they contributed equally to this article, they are the co-corresponding authors of this manuscript; and all authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zoran M Gluvic, MD, PhD, Associate Professor, Department of Endocrinology, University Clinical-Hospital Centre Zemun-Belgrade, Faculty of Medicine, University of Belgrade, Vukova 9, Belgrade 11080, Serbia. zorangluvic@yahoo.com
Received: August 16, 2024
Revised: January 13, 2025
Accepted: January 21, 2025
Published online: June 16, 2025
Processing time: 185 Days and 21.8 Hours

Abstract

Acute pancreatitis recurrence should always alert clinicians to primary hyperparathyroidism, especially in younger patients and those with a hereditary condition. When parathyroid abnormalities are adequately recognized and addressed, more recurrent attacks of acute pancreatitis are unlikely to occur.

Key Words: Acute pancreatitis; Parathyroid hormone; Primary hyperparathyroidism; Ultrasound; Scintigraphy; Dual-energy X-ray absorptiometry

Core Tip: Primary hyperparathyroidism is a very uncommon cause of acute pancreatitis. Medical management may go unreported due to primary hyperparathyroidism’s gradual progression and, on occasion, normal parathyroid hormone levels despite hypercalcemia. The diagnosis and treatment of juvenile acute pancreatitis, particularly in its recurrent form, require a comprehensive work-up. Clinicians need to be aware that recurrent juvenile pancreatitis may be caused by primary hyperparathyroidism.



TO THE EDITOR

In gastroenterology, acute pancreatitis is one of the most frequent diagnoses at admission[1]. It is defined as a predominantly sterile pancreatic inflammation caused by aberrant enzyme activation. It produces an inflammatory response with a broad range of histological findings, from moderate edema to severe gland necrosis[1,2]. Regardless of the etiology, recurrent acute pancreatitis is characterized by two or more episodes of acute pancreatitis, with a symptom-free interval in between and no evidence of chronic pancreatitis[3]. Gallstones and ethanol consumption account for 70% of the cases of acute pancreatitis. Smoking, drug use (glucocorticoids, azathioprine, acetaminophen, furosemide, thiazides, lithium, carbamazepine, valproic acid, etc.), trauma, medical procedures (endoscopic retrograde cholangiopancreatography), infections (mumps), vascular diseases (polyarteritis nodosa, anti-neutrophil cytoplasmic antibody vasculitis), metabolic abnormalities (hypercalcemia, hypertriglyceridemia), and autoimmunity are other less frequent causes[1-3].

CASE REPORT ANALYSIS AND REVIEW OF THE LITERATURE

In this case report, the authors highlight how a juvenile patient’s acute pancreatitis was caused by undiagnosed primary hyperparathyroidism (PHPT)[4]. Despite hypercalcemia, the initial laboratory analysis revealed normal parathyroid hormone (PTH) levels, thus delaying the accurate diagnosis. Another episode of severe pancreatitis necessitated more extensive diagnostic tests and procedures, and a parathyroid adenoma was discovered during neck ultrasonography (US) and parathyroid scintigraphy. No additional pancreatitis attacks were observed following the successful surgical removal of the parathyroid adenoma[4]. The most common cause of PHPT is a single parathyroid adenoma, but additional causes include parathyroid malignancy and parathyroid hyperplasia, sometimes as the component of multiple endocrine neoplasia syndromes (MEN 1, MEN 2A). Persistent hypercalcemia results from unregulated PTH synthesis, which increases renal reabsorption of calcium and mobilizes calcium from the bone[5].

According to a study by Rashmi et al[6], the prevalence of acute pancreatitis in PHPT is 9.8%. Individuals who have both acute pancreatitis and PHPT tend to be younger and male[7]. Hypercalcemia is the primary cause of recurrent pancreatitis in PHPT patients. In addition to enhancing the formation of pancreatic calculi and ductal obstruction, it also promotes the conversion of trypsinogen to trypsin (the pancreatic autodigestion enzyme). This results in acute pancreatitis or recurrent episodes of chronic pancreatitis, particularly in individuals who are genetically predisposed[7-12]. Typically, the diagnosis of PHPT is mostly neglected before the occurrence of two or more pancreatitis episodes[1,3,11]. In one case report, acute pancreatitis occurred four times in 15 months in a 32-year-old male[12]. The association between PHPT and pancreatitis does not correlate just with acute but also subacute and chronic calcifying pancreatitis[13,14]. Another trick in the presented case was normal levels of serum PTH associated with hypercalcemia. Normohormonal PHPT incidence is a notable factor, ranging from 3% to 10.5%. This term refers to patients exhibiting normal PTH levels alongside hypercalcemia. These individuals are typically younger and present greater challenges in recognition and management[15].

PHPT is diagnosed by measuring serum calcium and PTH levels. In most patients with PHPT, both levels are elevated. Occasionally, an individual may present with normal or mildly elevated serum PTH levels alongside hypercalcemia. An elevated or normal PTH level suggests PHPT, as serum PTH is expected to be low in increased calcium levels. Individuals with familial hypocalciuric hypercalcemia exhibit this appearance, which results from a rare heterozygous mutation in the gene encoding the calcium-sensing receptor, leading to a lifelong elevation in serum calcium levels. Alterations in PTH levels frequently coincide with vitamin D deficiency; however, hypercalcemia is rare. Accurate diagnosis of PHPT involves measuring serum PTH, calcium, and 25-hydroxyvitamin D levels, along with urine calcium and creatinine excretion. Additionally, calculating the calcium/creatinine excretion ratio and conducting genetic panel testing for familial hypocalciuric hypercalcemia are essential components of the diagnostic process[16-18].

Parathyroid US serves as the principal imaging technique for assessing parathyroid disease. It has a sensitivity of 85% (95% confidence interval: 75.7%-91.2%) and a positive predictive value (PPV) of 95.2% (95% confidence interval: 87.5%-98.4%) to locate parathyroid adenomas 1.7 cm ± 0.9 cm in maximum diameter (69.4% in smaller glands), showing a significant correlation with maximum diameter and volume of the excised adenoma. The integration of technetium-99 methoxy-isobutyl-isonitrile scintigraphy with neck US exhibited enhanced diagnostic efficacy, achieving a sensitivity of 96.8% and a predictive value of 95.8%[19]. Additionally, the patients with PHPT undergo assessment for end-organ damage and complications through multiple diagnostic methods. Bone density is assessed by dual-energy X-ray absorptiometry. Serum creatinine is measured to evaluate kidney function, while 24-hour urine calcium excretion is assessed to determine kidney stone risk in patients with PHPT. Abdominal X-rays and US, or computed tomography, are utilized to identify silent kidney stones[16,17,19].

CONCLUSION

This case study shows the need to precisely determine the cause of a disease to prevent recurrences. In a young male patient presenting with recurrent pancreatitis, lacking a history of alcoholism or smoking, and with negative gallstone radiology, PHPT should be considered as a potential causative factor. A comprehensive investigation is warranted, even in the presence of hypercalcemia and normal serum PTH levels. Effective PHPT management can prevent pancreatic disease recurrence.

Footnotes

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Medicine, research and experimental

Country of origin: Serbia

Peer-review report’s classification

Scientific Quality: Grade C, Grade C, Grade D

Novelty: Grade B, Grade B,Grade C

Creativity or Innovation: Grade C, Grade C, Grade C

Scientific Significance: Grade B, Grade C, Grade B

P-Reviewer: Kumar A; Tuan Ismail TS S-Editor: Bai Y L-Editor: A P-Editor: Wang WB

References
1.  Beyer G, Hoffmeister A, Lorenz P, Lynen P, Lerch MM, Mayerle J. Clinical Practice Guideline—Acute and Chronic Pancreatitis. Dtsch Arztebl Int. 2022;119:495-501.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in RCA: 13]  [Reference Citation Analysis (0)]
2.  Sohail Z, Shaikh H, Iqbal N, Parkash O. Acute pancreatitis: A narrative review. J Pak Med Assoc. 2024;74:953-958.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
3.  Beyer G, Hoffmeister A, Michl P, Gress TM, Huber W, Algül H, Neesse A, Meining A, Seufferlein TW, Rosendahl J, Kahl S, Keller J, Werner J, Friess H, Bufler P, Löhr MJ, Schneider A, Lynen Jansen P, Esposito I, Grenacher L, Mössner J, Lerch MM, Mayerle J; Collaborators:. S3-Leitlinie Pankreatitis – Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – September 2021 – AWMF Registernummer 021-003. Z Gastroenterol. 2022;60:419-521.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in RCA: 13]  [Article Influence: 4.3]  [Reference Citation Analysis (1)]
4.  Karim MM, Raza H, Parkash O. Recurrent acute pancreatitis as an initial presentation of primary hyperparathyroidism: A case report. World J Clin Cases. 2024;12:6302-6306.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (1)]
5.  Bai HX, Giefer M, Patel M, Orabi AI, Husain SZ. The association of primary hyperparathyroidism with pancreatitis. J Clin Gastroenterol. 2012;46:656-661.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 58]  [Cited by in RCA: 59]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
6.  Rashmi KG, Kamalanathan S, Sahoo J, Naik D, Mohan P, Pottakkat B, Kar SS, Palui R, Roy A. Primary hyperparathyroidism presenting as acute pancreatitis: An institutional experience with review of the literature. World J Gastrointest Pharmacol Ther. 2022;13:47-56.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in RCA: 4]  [Reference Citation Analysis (34)]
7.  Misgar RA, Bhat MH, Rather TA, Masoodi SR, Wani AI, Bashir MI, Wani MA, Malik AA. Primary hyperparathyroidism and pancreatitis. J Endocrinol Invest. 2020;43:1493-1498.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in RCA: 6]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
8.  Agarwal A, George RK, Gupta SK, Mishra SK. Pancreatitis in patients with primary hyperparathyroidism. Indian J Gastroenterol. 2003;22:224-225.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Bist SS, Ahuja V, Agrawal V, Modi S. Recurrent Acute Pancreatitis: A Diagnostic Clue to Primary Hyperparathyroidism. Iran J Med Sci. 2016;41:361-362.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Chowdhury SD, Kurien RT, Pal S, Jeyaraj V, Joseph AJ, Dutta AK, Chandramohan A, Abraham D, Augustine J, Hephzibah J, Simon EG. Acute pancreatitis and hyperparathyroidism: a case series. Indian J Gastroenterol. 2014;33:175-177.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in RCA: 9]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
11.  HAVERBACK BJ, DYCE B, BUNDY H, EDMONDSON HA. Trypsin, trypsinogen and trypsin inhibitor in human pancreatic juice. Am J Med. 1960;29:421-433.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 167]  [Cited by in RCA: 130]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
12.  COPE O, CULVER PJ, MIXTER CG Jr, NARDI GL. Pancreatitis, a diagnostic clue to hyperparathyroidism. Ann Surg. 1957;145:857-863.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 159]  [Cited by in RCA: 136]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
13.  Misgar RA, Mathew V, Pandit K, Chowdhury S. Primary hyperparathyroidism presenting as recurrent acute pancreatitis: A case report and review of literature. Indian J Endocrinol Metab. 2011;15:54-56.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in RCA: 17]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
14.  Carnaille B, Oudar C, Pattou F, Combemale F, Rocha J, Proye C. Pancreatitis and primary hyperparathyroidism: forty cases. Aust N Z J Surg. 1998;68:117-119.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 80]  [Cited by in RCA: 68]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
15.  Fedorova T, Hagglund K, Hawasli A. The Normohormonal Primary Hyperparathyroidism; a surgical dilemma pre and intra-operatively. Am J Surg. 2022;223:589-591.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Reference Citation Analysis (0)]
16.  Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S, Perrier N, Sitges-Serra A, Thakker RV, Guyatt G, Mannstadt M, Potts JT, Clarke BL, Brandi ML; International Workshop on Primary Hyperparathyroidism. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res. 2022;37:2293-2314.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in RCA: 155]  [Article Influence: 51.7]  [Reference Citation Analysis (0)]
17.  El-Hajj Fuleihan G, Chakhtoura M, Cipriani C, Eastell R, Karonova T, Liu JM, Minisola S, Mithal A, Moreira CA, Peacock M, Schini M, Silva B, Walker M, El Zein O, Marcocci C. Classical and Nonclassical Manifestations of Primary Hyperparathyroidism. J Bone Miner Res. 2022;37:2330-2350.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in RCA: 16]  [Article Influence: 5.3]  [Reference Citation Analysis (0)]
18.  Hannan FM, Kallay E, Chang W, Brandi ML, Thakker RV. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat Rev Endocrinol. 2018;15:33-51.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 259]  [Cited by in RCA: 215]  [Article Influence: 30.7]  [Reference Citation Analysis (0)]
19.  Carral F, Ayala MDC, Jiménez AI, García C, Robles MI, Vega V. High capacity of ultrasound for locating parathyroid adenomas in endocrinology (the ETIEN 4 study). Endocrinol Diabetes Nutr (Engl Ed). 2020;67:272-278.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in RCA: 2]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]